Takeda Global Research & Development Center, Inc.
🇺🇸United States
Lundbeck and Takeda Seek FDA Approval for Antidepressant Drug
Takeda Pharmaceuticals and Lundbeck have submitted a New Drug Application to the FDA for vortioxetine, an investigational antidepressant for treating major depressive disorder in adults. The application includes data from global clinical trials involving 7,500 individuals, showing significant efficacy.
© Copyright 2025. All Rights Reserved by MedPath